Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 824 results for "pfizer drugmaker pfizer"

Pfizer won't split in 2 (PFE)
Business Insider

BRIEF-Genfit H1 net loss widens to 12.7 million euros

UPDATE 3-Pfizer abandons plan to split into two companies Sept 26 U.S. drugmaker Pfizer Inc, which has been considering a split into two companies for more than two years, said on Monday it would not do so because the move would not create any ... Reuters UK, 2 hours ago

3 Biotechs That Could Be M&A Targets

After Pfizer, Inc. agreed to pay 14 times forecast sales for 2016to acquire cancer drugmaking pure play Medivation last month, shares in other cancer-focused biotech companies shot higher. While it doesn't make sense to buy shares in all the ...
 FOXBusiness.com2 days ago
Deccan Chronicle

Drug firms join antibiotic fight

Mumbai : Thirteen leading drugmakers like Pfizer and GSK on Tuesday have promised to curb the overuse of antibiotics and clean up pollution from factories making antibiotics as part of a drive to fight the rise of drug-resistant superbugs. ...
 Deccan Chronicle5 days ago ‘Superbugs’ force antibiotic clean-up  Asian Age5 days ago Drugmakers including Cipla, Wockhardt pledge to clean up antibiotic factories, curb overuse  Yahoo! Singapore6 days ago Drugmakers pledge to clean up antibiotic factories, curb overuse  Yahoo! News6 days ago
Motley Fool

Better Buy: Pfizer Inc. vs. AbbVie Inc.

IMAGE SOURCE: . Big pharma is on a roll. Several of the largest drugmakers' stocks are up by double-digit percentages over the past six months. Count AbbVie ( NYSE:ABBV ) and Pfizer ( NYSE:PFE ) among big pharma's best performers in 2016: ...
 Motley Fool1 week ago
Yahoo! India

Pfizer To Buy Cancer Drug Firm Medivation For £10bn

News of the acquisition pushed Medivation's stock price up almost 20 percent on Monday morning, with shares trading around $80 a share, close to the pfizer offer price. The deal is expected to be paid for by Pfizer in its entirety, or at least ...
 Equilibrio Informativo3 weeks ago Pfizer to Purchase Medivation for $14 Billion  FDA News1 month ago Pfizer is paying $14 billion for Medivation - and the cancer drugmaker's shares are soaring  Business Insider India1 month ago Pfizer Confirms $14 Billion Takeover of Cancer Drugmaker Medivation  TheStreet.com1 month ago

Clinton's Drug Proposals Very Negative, Pfizer CEO Says

The head of Pfizer Inc., America's biggest drugmaker, said that Democratic presidential nominee Hillary Clinton's proposals to contain the price of pharmaceuticals would be very negative for medical innovation and are a step toward single-payer ...
 Yahoo! Finance2 weeks ago Pfizer CEO Shakes Head at Drug Pricing Plan  BioSpace2 weeks ago Clinton Drug Proposal Very Negative, Pfizer CEO Says  Bloomberg2 weeks ago
Bidness Etc

Pfizer on buying spree with AstraZeneca antibiotics deal

TRENTON, N.J. Drugmaker Pfizer Inc. is continuing its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in ...
 FOXBusiness.com1 month ago Pfizer Acquires AstraZenecas Antibiotics Assets, After Failing to Buy Entire Company  Mergers & Acquisitions1 month ago Pfizer acquires AstraZeneca antibiotics  SiliconValley.com1 month ago Gilead Sciences, Inc. Can Fancy TESARO Inc for Acquisition  Bidness Etc1 week ago

Regeneron, in Pain Drug Race With Pfizer & Lilly, Gets $250M From Teva

September 20th, 2016 Xconomy New York — Millions of people in the U.S. suffer from chronic forms of pain, but the treatment options aren't great. Regeneron Pharmaceuticals is locked in a race with Eli Lilly and Pfizer to develop an ...
 Xconomy6 days ago Regeneron, Teva take aim at Lilly/Pfizer pain drug  Sharenet6 days ago REUTERS - Regeneron, Teva take aim at Lilly/Pfizer pain drug  Namibia Press Agency6 days ago Regeneron, Sanofi Topple Despite Eczema Drug Win  Investor's Business Daily47 minutes ago

PFIZER : Behind the EpiPen controversy are questions about patents granted to drugmaker

Sept. 03--Drugmaker Mylan NV has received the brunt of criticism for alleged price-gouging on the lifesaving EpiPen, but other factors -- and players -- contributed to the monopoly it enjoys today, say experts familiar with the drug industry. First ...
 4 Traders3 weeks ago EpiPen maker Mylan dispenses outsized executive pay  MSN News US1 week ago Behind the EpiPen controversy are questions about patents granted to drugmaker [St. Louis Post-Dispatch]  Pharmacy Choice3 weeks ago Pfizer : St. Louis area manufacturer of EpiPens to produce Mylan's new generic version  4 Traders3 weeks ago

Medivation Proxy Shows Pfizer Battled Four Bidders to Seal a Deal

A regulatory document filed by Medivation revealed that Pfizer competed with four other drugmakers to acquire the biotech firm, TheStreet reported Wednesday. Earlier this year, Pfizer agreed to pay $81.50 per share in cash, or $14 billion, to ...
 FirstWord Pharma3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less